Simplex Trading
RUBY

Simplex Trading’s Rubius Therapeutics, Inc RUBY Stock Holding History

Simplex Trading’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8,800
Closed -$48K – 11566
2022
Q1 		$48K Buy
8,800
+5,200
+144% +$33K ﹤0.01% 7205
2021
Q4 		$34K Buy
3,600
+1,300
+57% +$18K ﹤0.01% 7754
2021
Q3 		$59K Hold
2,300
– – ﹤0.01% 7327
2021
Q2 		$56K Buy
2,300
+2,091
+1,000% +$52.3K ﹤0.01% 7522
2021
Q1 		$553K Buy
209
+188
+895% +$2.75K ﹤0.01% 3228
2020
Q4 		$15K Buy
+21
New +$125 ﹤0.01% 7177

Simplex Trading's RUBY Position: Q2 2023 in Review

Simplex Trading sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2023, closing a stake of 3,856 shares.

Simplex Trading first reported a position in RUBY in Q1 2021 and held it in 7 quarters. The position peaked at $585K in Q1 2022. 0 funds tracked by Wall St. Rank hold RUBY as of Q2 2023.

  • Simplex Trading reported no remaining Rubius Therapeutics, Inc position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 3,856 Rubius Therapeutics, Inc shares in Q2 2023.
  • Simplex Trading first reported a position in Rubius Therapeutics, Inc in Q1 2021 and held it in 7 quarters.
  • Simplex Trading's Rubius Therapeutics, Inc position peaked at $585K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.